Adicon Holdings Limited (9860.HK)
| Previous close | 8.850 |
| Open | 8.780 |
| Bid | 8.910 x N/A |
| Ask | 8.960 x N/A |
| Day's range | 8.720 - 9.090 |
| 52-week range | 8.500 - 19.180 |
| Volume | |
| Avg. volume | 1,042,799 |
| Market cap | 6.517B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 26.35 |
| EPS (TTM) | 0.340 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 15.76 |
Simply Wall St.May 2024 SEHK Growth Leaders With High Insider Ownership
As of May 2024, the Hong Kong market is experiencing a notable upswing, with the Hang Seng Index climbing 2.64% recently, reflecting positive investor sentiment amid recovery hopes fueled by robust holiday spending and trade data. This buoyant backdrop sets an intriguing stage for examining growth companies in Hong Kong that boast high insider ownership—a factor often linked with strong corporate governance and aligned interests between shareholders and management.
- PR Newswire
Adicon Holdings Limited (9860.HK): Continuous growth in Core Operations, Consistent Profitability Enhancement
Adicon Holdings Limited (the "Company" or "Adicon"), one of the largest independent clinical laboratory (ICL) service providers listed on the Stock Exchange of Hong Kong (SEHK), has released its interim results for the first half of 2023. As a leading player in delivering ICL services in China, the Company has maintained a robust performance, marked by a significant improvement in profitability.
